RIPPMANN, Joerg,KLEIN, Thomas,MARK, Michael,MAYOUX, Eric, Williams
申请号：
PH12019500845
公开号：
PH12019500845A1
申请日:
2019.04.17
申请国别(地区):
PH
年份:
2019
代理人:
摘要：
The invention relates to a pharmaceutical combination according to the invention comprising an SSAO/VAP-1 inhibitor according to the formula (I) wherein R1 to R6, and X are as defined herein, and an SGLT2 inhibitor. In addition the present invention relates to methods for preventing, slowing the progression of, delaying or treating fibrotic disorders, metabolic disorders, inflammation disorders, ocular diseases, neuroinflammatory disorders or cancer in a patient in need thereof characterized in that the pharmaceutical combination according to the invention is administered to the patient.
